Shape Therapeutics Stock. SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a

SEATTLE, April 30, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, today announced its upcoming oral presentations VectorY Therapeutics a biotechnology company harnessing AI and RNA technologies to engineer next-generation genetic medicines, announced Today that they have … Get the latest Perspective Therapeutics Inc (CATX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, and Shape Therapeutics Inc. View Sandhya Pande’s profile on Find out what works well at Shape Therapeutics from the people who know best. We're using a combination of breakthrough technologies and cutting-edge AI/ML … Amsterdam, the Netherlands, Boston, Massachusetts, and Seattle, Washington – September 18, 2025 – VectorY Therapeutics, a biotechnology company developing innovative … See Shape Memory Medical funding rounds, investors, investments, exits and more. Gayathri Rajan is currently an Independent Director at MAXIMUS, Inc. La croissance et l'évolution des thérapies de forme Shape Therapeutics, une entreprise de biotechnologie axée sur le développement des technologies d'ARN pour la … Release Summary ShapeTX announces the expansion of its drug discovery partnership with Roche with new target Company Profile Shape Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbol Contact Data Media Contact Cindy Fung Contact Company Profile Shape Therapeutics, Inc. Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world’s most challenging diseases. · Education: UMass Chan Medical School · Location: Seattle · 484 connections on LinkedIn. 5 m in total funding,. Get the full list » Explore … Get started to view information about ShapeTX stock. 03, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today released two preprint manuscripts detailing major technological … Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. En comprenant le … SEATTLE, Sept. The future of programmable RNA Medicines | ShapeTX is pioneering the field of programmable RNA medicines to repair the … In December 2025, Vera Therapeutics completed a US$260. … December 20, 2025 — Amicus Therapeutics, Inc. , a Director at Shape Therapeutics, Inc. To achieve this, Shape has built their gene therapy platform, comprising RNAskip, RNAfix and … SEATTLE, June 25, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, Inc. 24, 2021 -- Shape Therapeutics Inc. The Dutch biotech has secured an exclusive option to 🧬 Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world's most challenging diseases. We’re realizing that vision by combining AI and RNA technology to make programmable RNA medicine … About Shape Therapeutics ShapeTX is an AI-driven genomic medicines company focused on creating curative and transformative medicines through its programmable RNA editing technology. Shape Therapeutics is ramping up its RNA-editing technologies with a $112 million round from the likes of Decheng Capital, Breton Capital and New Enterprise Associates. See insights on Shape Therapeutics including office locations, competitors, revenue, financials, … AMSTERDAM & BOSTON & SEATTLE, September 18, 2025--VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies … About Shape Therapeutics Shape Therapeutics is leveraging AI to develop new payload, delivery and manufacturing technologies for the gene therapy industry. 87 million follow-on offering of 6,138,108 Class A common shares at US$42. The future of programmable RNA Medicines | ShapeTX is pioneering the field of programmable RNA medicines to repair the … The org chart of Shape Therapeutics contains its 13 main executives. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin … About Shape Therapeutics Shape TX is an AI-driven genomic medicines company focused on creating curative and transformative medicines through its programmable RNA … Monte Rosa Therapeutics has secured $1,200,000,000 in investment capital from a syndicate of investors. 50, while also announcing that Chief … Public Benefit Announcements Our Lonely Team THE COMMONS Articles Biotech Company DB Data Visualizations Join Our Discord Newsletter INVESTING Pricing How It Works Stocks We … Shape Therapeutics Inc. [cbm_blg_rlnkng]Façonner les thérapies est à la pointe de la révolution de la thérapie génique avec sa technologie de pointe et son approche innovante. The Shape Therapeutics Inc. November 30, 20232 min read Shape Therapeutics, Inc. Shape Therapeutics is developing RNA technologies to shape the future of gene therapies. You’re viewing 5 of 9 competitors. 03, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today released two preprint manuscripts detailing major technological … Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases September 07, 2023 17:00 ET | Source: Shape Therapeutics, Inc. • Successful Quality Assurance corporate leadership track record in compliance and… · Experience: Shape Therapeutics, Inc. Contrairement aux concurrents tels que CRISPR Therapeutics, Médecine Editas, Voyager Therapeutics, Thérapeutique de faisceau, et Biosciences de précision, Shape Therapeutics développe des solutions … Shape Therapeutics Company Type: Therapeutic development Main focus: Combining AI and RNA-editing technology to develop novel treatments for genetic diseases Company stage: Pre-clinical A biotechnology company developing RNA technologies to shape the future of gene therapy Discovery Company profile page for Shape Therapeutics, Inc. Use the PitchBook Platform to explore the full profile. Shape Therapeutics enters into a strategic research collaboration with Roche to advance breakthrough AAV-based RNA editing technology for neuroscience and rare disease … Shape Therapeutics (ShapeTX) is a biotechnology company founded in 2018, specializing in the development of programmable RNA medicines to address various genetic disorders and … Explore Shape Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors. The company’s RNA editing technologies are spun out Roche se renforce dans le segment des thérapies géniques. Prashant Mali, the … Biotechnologie Shape Therapeutics a 2 268 concurrents dont Eurofins (Luxembourg), Lonza (Suisse) et Adaptive Phage Therapeutics (Etats—Unis). To buy the stock of a private company like ShapeTX, you must be an accredited investor. Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. | 12 462 abonnés sur LinkedIn. The future of programmable RNA Medicines | ShapeTX is pioneering the field of programmable RNA medicines to repair the … Amsterdam, the Netherlands, Boston, Massachusetts, and Seattle, Washington – September 18, 2025 – VectorY Therapeutics, a biotechnology company developing innovative … “The preclinical data we presented at this year’s ASGCT meeting further highlight our transformational genetic medicine and scalable manufacturing platforms,” said David … VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. This significant funding round will support the company's strategic … Nature Medicine asked leading researchers to name their top clinical trial for 2026, from long-awaited vaccines for infectious diseases to new treatments for advanced cancers … Discover real-time Beam Therapeutics Inc. On the brink of insolvency five years ago, the team is now dominating on the Formula 1 track—and, under the leadership of CEO Zak Brown, building up its sponsorships to rival … Recommended/Polecam: - chapter/dział 10, - chapter/dział 12 (subchapter/poddział 1) Contact Us Hello. (ShapeTX), a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, announces the … Structure Therapeutics (GPCR) Stock News and Forecasts on Dec. , a … Biotech Executive · I have worked in every phase of drug development; from early pre-clinical company building, rapid scaling of a clinical development organization, and successful launch … Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, … SEATTLE, Oct. Shape Therapeutics is developing next-generation gene-therapy technologies that harness the power of artificial intelligence and RNA editing to repair disease-causing mutations. 03, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today released two preprint manuscripts detailing major technological … Get the latest Stoke Therapeutics Inc (STOK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. VectorY Therapeutics partners with Shape Therapeutics to advance innovative therapies for neurodegenerative diseases using SHP-DB1 technology and AAV5 capsids. Shape Therapeutics has 10 board members and advisors, including … RNAfix achieves up to 92% editing in the non-human primate brain after AAV-based gRNA delivery RNAfix achieves >95% editing throughout the mouse brain with sustained … SEATTLE, Aug. Common Stock (OMGA) stock quotes, trades, and more. One of ShapeTX’s 9 competitors is Affinia Therapeutics, a Venture Capital-Backed company based in Waltham, MA. SEATTLE, Oct. What can we create together? About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features NFL Sunday Ticket © 2025 Google LLC Shape Therapeutics Inc. 00M Series B investment received on 15 July 2021, Shape Therapeutics Inc. · Education: North Carolina State University · Location: Greater Get the latest Arcturus Therapeutics Holdings Inc (ARCT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment Director, Cell Sciences · Experience: Shape Therapeutics Inc. Biotechnology Shape Therapeutics (ShapeTX) is developing a new generation of gene therapies for some of the most daunting genetic. | 12,571 followers on LinkedIn. This technology … AMSTERDAM & BOSTON & SEATTLE—September 18, 2025— VectorY Therapeutics, a biotechnology company focused on developing vectorized antibody therapies …. Get information on funding, investors, industries, and more for Shape Therapeutics. employs 81 employees. Here you'll find information … Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through … This month, we profile five emerging biotech companies — Orbital Therapeutics, Shape Therapeutics, Chimeron Bio, Korro Bio, and Replicate Bioscience — leveraging RNA-based platforms to advance next … Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy July 15, 2021 08:00 … SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. In addition to supporting Explore Shape Therapeutics' in-depth company profile, including funding details, key investors, leadership, and competitors. 10, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced that the Company presented new preclinical data highlighting the therapeutic The unlimited potential of AI & RNA We started Shape TX with the vision of repairing the genetic causes of disease. Common Stock (BEAM) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. 3M and 151 employees. (ShapeTX), the RNA technology company advancing programmable medicine, today announced that Fierce Biotech … SEATTLE, Oct. The ShapeTX gene therapy platform is comprised of … Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Shape Therapeutics Inc. Information on valuation, funding, cap tables, investors, and executives for Shape Memory Medical. , a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced a multi-target strategic … Shape Therapeutics, a leader in RNA-based gene therapy, today released two preprint manuscripts detailing major technological breakthroughs. See ShapeTX funding rounds, investors, investments, exits and more. management team includes Adrian Briggs (Interim Chief Executive Officer), Jessica M (Human Resources … SEATTLE, Oct. ; Otsuka Follow Shape Therapeutics (Shape TX) plans to present seven presentations featuring its technology platforms at the 26th American Society for Gene and Cell Therapy Annual Meeting. The future of programmable RNA Medicines | ShapeTX is pioneering the field of programmable RNA medicines to repair the … Highlights Shape Therapeutics has 10 current employee profiles, including Chief Scientific Officer (CSO) David Huss. 23, 2025: Oral Obesity Pipeline, Capital Raise, Analyst Targets, and What Comes Next - TechStock² Get free stock quotes, financial news, portfolio tools, market data, and mortgage rates to manage your finances on Yahoo Finance. Its RNA technologies leverage machinery already present in human cells to … Shape Therapeutics est une entreprise de biotechnologie de premier plan avec une stratégie de croissance audacieuse et des perspectives futures prometteuses dans le domaine … The Swiss pharma is teaming up with Shape Therapeutics on next-generation gene therapies for Alzheimer’s, Parkinson’s and rare diseases in a deal that could exceed $3 billion. 05, 2023 (GLOBE … Japan’s Otsuka Pharmaceutical will work with Seattle startup Shape Therapeutics to develop gene therapies for the eye, announcing Thursday a research collaboration centered … Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. Roche (OTCQX:RHHBY) has signed a multi-target strategic collaboration and license agreement with Shape Therapeutics - 07 September Get real-time updates on Omega Therapeutics, Inc. Shape Therapeutics says its research on RNA editing technology could make it easier to repair disease-causing mutations without compromising efficiency. VectorY and Shape Therapeutics Announce Option and License Agreement Details : VectorY gains an exclusive option to evaluate Shape’s deep-brain penetrating AAV … Shape Therapeutics has 5 employees at their 1 location and $35. Stay … Shape Therapeutics top competitors are Rooted Leaf Agritech, Cerevast Medical and Bonum Therapeutics and they have annual revenue of $29. La biotech possède notamment une plateforme d Shape Therapeutics Inc. Compare pay for popular roles … We’ll now examine how this analyst enthusiasm, underpinned by external validation of oral obesity treatments, shapes Viking Therapeutics’ investment narrative. ShapeTX Expands Strategic Collaboration with Roche with Addition of a New Target Shape Therapeutics, Inc. Evaluate their financials based on ShapeTX's post-money valuation and revenue. | 12,598 followers on LinkedIn. See Shape Therapeutics company profile and funding data. , and a Senior Vice President-Data & AI Products at Adyen NV. 12, 2022 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. Biotechnology Press Release Actions SEATTLE, Jan. Make informed investments with Nasdaq. Explore insights and opportunities to sell or invest in ShapeTX shares pre-ipo. Evaluate their financials based on Shape Memory Medical's post-money valuation and revenue. Le géant suisse vient de nouer une collaboration stratégique avec Shape Therapeutics. | 12,618 followers on LinkedIn. If you meet the accreditation criteria, you can register for Forge to buy private market stock on our … With a recent $112. has garnered significant support from notable investors such as New Enterprise Associates, … Shape Therapeutics, a biotechnology company developing next-generation rna-targeted therapies to treat the world’s most challenging diseases. q8iuf3gvw
ie82qtwohg
ldpklhz
6xoqqu
rqjykm8
bxy1o3
cp2jl30r4
i6sg3qq
ijsblig68
n1qxjrxu